An observational study in Healthy, sponsored by University of Copenhagen. Completed at 1 site in Denmark. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-01-15.
Sponsored by University of Copenhagen · Observational
This study aims to validate the use of the Ventriject product to estimate VO2 max, through a non-physically active test using ECG, echoseismography and echosonography.
this study will be composed of the following tests:
University of Copenhagen is the lead sponsor of 450 studies on the registry; 61 are open to participants now.
Counted across the registry records on this site, refreshed daily.
healthy adults
Exclusion Criteria:
comparing measurements from echocardiography, echoseismography to measurements of maximal oxygen uptake
Comparing how well the Ventriject software can estimate VO2 max
VO2 max tested on bike with online software Ventriject will estimate VO2max based on ECG, echoseismography and echosonography obtained at rest
Time frame: 4 months data collection, although cross sectional
comparing how well the measurements from the mobile phone test compare to the same measurements with accelerometer and echosonography
comparison of ECG, echoseismography and echosonography obtained at rest to a measurement of movement (caused by heart contraction) by mobile phone, also at rest
Time frame: 4 months data collection, although cross sectional
Plan to share: Undecided — Sharing of IPD is possible if the following terms are met: 1. Identification of the study participant is in no way achieveable from the requested data 2. The participant declares interest in their data being shared through IPD
No publications or documents are linked to this record.
This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Copenhagen